These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 21235130)
1. Differential equations with small parameter with applications in radioimmunotherapy. Ilea M; Turnea M; Arotăriţei D; Toma CM Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):937-42. PubMed ID: 21235130 [TBL] [Abstract][Full Text] [Related]
2. Ordinary differential equations with applications in molecular biology. Ilea M; Turnea M; Rotariu M Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):347-52. PubMed ID: 23077920 [TBL] [Abstract][Full Text] [Related]
3. Targeted therapy of cancer with radiolabeled antibodies. Goldenberg DM J Nucl Med; 2002 May; 43(5):693-713. PubMed ID: 11994535 [TBL] [Abstract][Full Text] [Related]
4. A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies. Wong JYC ; Chu DZ; Yamauchi DM; Williams LE; Liu A; Wilczynski S; Wu AM; Shively JE; Doroshow JH; Raubitschek AA Clin Cancer Res; 2000 Oct; 6(10):3855-63. PubMed ID: 11051230 [TBL] [Abstract][Full Text] [Related]
5. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model. Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986 [TBL] [Abstract][Full Text] [Related]
6. Differential equations with applications in cancer diseases. Ilea M; Turnea M; Rotariu M Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):572-7. PubMed ID: 24340548 [TBL] [Abstract][Full Text] [Related]
7. A pharmacokinetic model for radioimmunotherapy delivered through cerebrospinal fluid for the treatment of leptomeningeal metastases. Lv Y; Cheung NK; Fu BM J Nucl Med; 2009 Aug; 50(8):1324-31. PubMed ID: 19617331 [TBL] [Abstract][Full Text] [Related]
13. Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer. Postema EJ; Börjesson PK; Buijs WC; Roos JC; Marres HA; Boerman OC; de Bree R; Lang M; Munzert G; van Dongen GA; Oyen WJ J Nucl Med; 2003 Oct; 44(10):1690-9. PubMed ID: 14530488 [TBL] [Abstract][Full Text] [Related]
14. Radioimmunotherapy is an effective adjuvant treatment after cytoreductive surgery of experimental colonic peritoneal carcinomatosis. Koppe MJ; Hendriks T; Boerman OC; Oyen WJ; Bleichrodt RP J Nucl Med; 2006 Nov; 47(11):1867-74. PubMed ID: 17079821 [TBL] [Abstract][Full Text] [Related]
15. Optimization of radioimmunotherapy of solid tumors: biological impediments and their modulation. Jain M; Venkatraman G; Batra SK Clin Cancer Res; 2007 Mar; 13(5):1374-82. PubMed ID: 17309914 [TBL] [Abstract][Full Text] [Related]
18. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse. Sato N; Saga T; Sakahara H; Yao Z; Nakamoto Y; Zhang M; Kuroki M; Matsuoka Y; Iida Y; Konishi J J Nucl Med; 1999 Apr; 40(4):685-92. PubMed ID: 10210230 [TBL] [Abstract][Full Text] [Related]
19. Radioimmunotherapy of solid tumors by targeting extra domain B fibronectin: identification of the best-suited radioimmunoconjugate. Berndorff D; Borkowski S; Sieger S; Rother A; Friebe M; Viti F; Hilger CS; Cyr JE; Dinkelborg LM Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7053s-7063s. PubMed ID: 16203802 [TBL] [Abstract][Full Text] [Related]
20. Principles of radioimmunotherapy for hematologists and oncologists. Press OW; Rasey J Semin Oncol; 2000 Dec; 27(6 Suppl 12):62-73. PubMed ID: 11226002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]